Report : Asia Pacific N95 Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (With Exhalation Valve and Without Exhalation Valve), Distribution Channel (Online and Offline), End User (Healthcare, Construction N95, Manufacturing, Mining, Oil and Gas, and Others)
Offline Segment to Dominate APAC N95 Masks Market during 2021–2028
According to a new market research study on “APAC N95 Masks Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Distribution Channel, and End User” is expected to reach US$ 1,132.94 million by 2028 from US$ 420.82 million in 2021. The market is estimated to grow at a CAGR of 15.2% from 2021 to 2028. The report provides trends prevailing in the APAC N95 masks market along with the drivers and restraints pertaining to the market growth. Continuous demand for respiratory protective equipment is the major factor driving the growth of the APAC N95 masks market. However, issues associated with the availability of alternative protective products hinder the growth of APAC N95 masks market.
The APAC N95 masks market is segmented on the basis of product, distribution channel, end user, and country. By product, the APAC N95 masks market is bifurcated into without exhalation valve and with exhalation valve. The without exhalation valve segment dominated the market in 2020 and with exhalation valve segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the N95 masks market is segmented into offline and online. The offline segment dominated the market and online segment is expected to be the fastest growing during the forecast period. By end user, the APAC N95 masks market is segmented into construction; manufacturing; healthcare; mining, oil and gas; and others. The construction segment dominated the market in 2020 and healthcare segment is expected to be the fastest growing during the forecast period. In terms of country, the APAC N95 masks market is segmented into—China, Japan, India, Australia, South Korea, and Rest of APAC.
In case of COVID-19, APAC is highly affected specially India. According to the World Health Organization (WHO), “COVID-19 spreads primarily through droplets generated when an infected person coughs, sneezes or speaks. Surgical masks and N95 respirators are used to prevent the spread of respiratory infections. They are part of the personal protective equipment (PPE) used by health workers and are different from other types of masks used to protect from pollution or dust. As the coronavirus is transmitted via droplets of fluid from the nose or mouth, face masks are essential for health workers who are in direct contact with infected patients. In February 2020, Guan Xunze’s company created a new mask factory in just eleven days. The factory, with five production lines in northeastern China, made the much-needed N95 face masks which were in huge demand as infection numbers surged. Further, Honeywell has added a N95 face mask production line at our Fulgaon facility in India to help support frontline healthcare workers, emergency responders and government organizations responding to the COVID-19 pandemic. Additionally, As for N-95 masks, the country has gone from producing 2 million units per month to nearly 25-30 million units per month. There are currently 241 manufacturers of N95 masks in the country, and exports have been allowed. India has become a significant manufacturer of N-95 masks in a short time span. However, the use of surgical mask instead of N95 in the region will have a negative impact on the market. For instance, currently, of the 200 million masks China makes a day, only 600,000 are N95 standard masks, used by medical personnel, according to the National Development and Reform Commission, a state planning body. Provincial regulators have granted dozens of new licenses to open additional factories capable of producing top-grade masks, including those that meet the standards for use by health-care professionals.
3M COMPANY; ALPHA PRO TECH, LTD.; Ansell Limited; Cardinal Health Inc; Honeywell International Inc.; Kimberly-Clark Corporation; Medisca Inc; and Medline Industries, Inc.are the leading companies in the APAC N95 masks market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, 3M has raised its annual production rate to 2.5 billion N95 respirators, a fourfold rise over 2019. In 2020, the company manufactured 2 billion respirators globally.